I was in denial - too embarrassed and ashamed to admit to it. My GP gave me short-acting beta blockers to calm me down - which I would take half an hour before doing anything I anticipated might ...

This study describes coformulations with short-acting beta-blockers or nitrates, matched to DMT’s pharmacokinetics, to mitigate peripheral cardiovascular risks without compromising central therapeutic ...

GLP1RA medications include the short-acting types lixisenatide ... or an angiotensin receptor blocker (ARB). beta blockers, and calcium channel blockers among others. Dyslipidemia (high ...

9 In several published case reports, a combination of a short-acting beta-blocker (eg, esmolol, propranolol), procainamide or lidocaine with electrolyte correction successfully treated cardiac ...

WASHINGTON -- Across the different classes of heart failure (HF) drugs, beta-blockers stood out for their association with limb loss in patients with concomitant chronic limb-threatening ischemia ...

It has been assumed that β-AR antagonists (β-blockers) have a direct favorable influence on the heart, but our results challenge this view, suggesting that β-blockers may also act directly in ...

During the conversation, Berner opened up about her experience of taking a beta-blocker before a "make or break" Netflix special. In the April 29 episode of Good Hang with Amy Poehler on YouTube ...

Without question, there is a fair deal of negative stigma surrounding traditional psychopharmaceutical treatments for problems such as anxiety, depression, and panic. While these medications of ...

More information: Camille Malatt et al, Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's disease, Journal of Neurology ...

However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF, where differences in reverse ...

WILMINGTON, Del., May 02, 2025--(BUSINESS WIRE)--Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose ...